Bell Bank
Source: SEC Form 13F · as of Mar 2026Bell Bank holds 15 biotech & pharma companies tracked by BioSniper, totaling $69.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$69.8M
| Company | Shares | Value |
|---|---|---|
| PFEPFIZER INC | 472,862 | $13.3M |
| ABBVAbbVie Inc. | 53,651 | $11.7M |
| AMGNAMGEN INC | 32,282 | $11.4M |
| GILDGILEAD SCIENCES, INC. | 76,657 | $10.7M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 182,228 | $10.1M |
| VTRSViatris Inc | 535,974 | $7.2M |
| LLYELI LILLY & Co | 2,280 | $2.1M |
| JNJJOHNSON & JOHNSON | 5,218 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,966 | $532K |
| MRKMerck & Co., Inc. | 3,120 | $375K |
| BMYBRISTOL MYERS SQUIBB CO | 5,114 | $310K |
| ABTABBOTT LABORATORIES | 2,419 | $248K |
| REGNREGENERON PHARMACEUTICALS, INC. | 301 | $233K |
| MCKMcKesson Corporation | 261 | $226K |
| BIIBBIOGEN INC. | 1,109 | $203K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.